Broadview Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Broadview Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-168,960	Closed	-$2.78M	–	101
2014 Q4	$2.78M	Buy	168,960 +650	+0.4%	+$11.2K	0.28%	74
2014 Q3	$2.98M	Sell	168,310 -665,875	-80%	-$13.1M	0.33%	69
2014 Q2	$17.2M	Buy	834,185 +191,550	+30%	+$3.94M	1.67%	16
2014 Q1	$14M	Buy	642,635 +76,350	+13%	+$1.75M	1.4%	26
2013 Q4	$15M	Sell	566,285 -150	-0%	-$3.69K	1.62%	20
2013 Q3	$13.4M	Hold	566,435	–	–	1.55%	20
2013 Q2	$12.2M	Buy	+566,435	New	+$12.2M	1.71%	17

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Broadview Advisors's VIVO Position: Q1 2015 in Review

Broadview Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2015, closing a stake of 168,960 shares — an estimated $2.78M sold.

Broadview Advisors first reported a position in VIVO in Q2 2013 and held it in 7 quarters. The position peaked at $17.2M in Q2 2014. 159 funds tracked by Wall St. Rank hold VIVO as of Q1 2015.

Broadview Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2015 after selling out during the quarter.
Broadview Advisors sold 168,960 Meridian Bioscience Inc shares in Q1 2015, an estimated $2.78M.
Broadview Advisors first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 7 quarters.
Broadview Advisors's Meridian Bioscience Inc position peaked at $17.2M in Q2 2014.
159 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2015.

Based on Broadview Advisors's 13F filing for Q1 2015, filed 15 May 2015.